Allergy transfer upon solid organ transplantation has been reported in the literature, although only few data are available as to the frequency, significance, and management of these cases. Based on a review of 577 consecutive deceased donors from the Swisstransplant Donor-Registry, 3 cases (0.5%) of fatal anaphylaxis were identified, 2 because of peanut and 1 of wasp allergy. The sera of all 3 donors and their 10 paired recipients, prospectively collected before and after transplantation for the Swiss Transplant Cohort Study, were retrospectively processed using a commercial protein microarray fluorescent test. As early as 5 days posttransplantation, newly acquired peanut-specific IgE were transiently detected from 1 donor to 3 recipients, of whom 1 liver and lung recipients developed grade III anaphylaxis. Yet, to define how allergy
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| INTRODUC TI ON
Anaphylaxis is a frequent cause of hospitalization with an estimated annual fatality rate of ≈0.5 per 1 000 000. Food allergy being the most common cause for anaphylaxis in children and young adults, death due to food allergy was found in ≈25% of the reported patients. 1 Peanuts or tree-nuts were the causative allergens in >70% of the cases in which the responsible allergen was identified. Other allergens frequently involved in fatal anaphylaxis are fish, milk, and egg but also bee and wasp venom, and drugs. 1 The first cases of transplant-associated allergy transfer were reported after hematopoietic stem cell transplantation, likely caused by IgE-specific B cells or T helper type 2 cells that were cotransferred with hematopoietic stem and progenitor cells. 2 Subsequently, cases of allergy transfer were also described after solid organ transplantation (SOT), predominantly after liver, lung, or combined pancreaskidney transplantation ( Table 1) . [3] [4] [5] [6] [7] [8] [9] [10] [11] Only very few data are available as to the frequency, significance and mechanisms of IgE transfer in the setting of SOT. In addition, the impact of immunosuppression on IgE sensitization is poorly understood. The objectives of this study were (1) to identify the frequency and significance of allergy transfer based on retrospective analysis from the Swiss Transplant Donor Registry and the Swiss Transplant Cohort Study (STCS); (2) to evaluate whether allergy testing is feasible early after SOT; and
(3) to make recommendations for the diagnosis and management of allergy transplant after SOT.
| MATERIAL AND ME THODS

| Donor-to-recipient IgE transfer
We retrospectively reviewed the data of 577 consecutive deceased donors from the Swisstransplant Donor-Registry (from January 2012 to May 2017) and identified 3 donors who died of anaphylaxis. In this registry, the individual history of severe allergy was not recorded. We then collected the prospectively stored sera of each donor-paired recipient from the STCS (Table 2) 
| Immunosuppression and IgE sensitization
Skin prick tests (SPT), specific IgE values, and clinical symptoms were monitored in 5 adult living-donor kidney transplant recipients with symptomatic allergic rhinoconjunctivitis between November 2016 and August 2018. The rhinoconjunctivitis score was based on the subject's nasal (runny nose, blocked nose, sneezing, itchy nose) and eye symptoms (gritty feeling/red/itchy eye and watery eye) using a 3-point scale (none = 0, slight symptoms = 1, moderate symptoms = 2, and severe symptoms = 3) for the 6 symptom classes. All recipients gave written informed consent (ID 2018-00965, CER-VD).
| RE SULTS
| Donor case 1
One young organ donor died of peanut-allergy-induced anaphylaxis leading to cardiac arrest with subsequent brain death. Upon admission, tryptase was >100 ng/mL (normal results: <10 ng/mL). With the consent of the relatives, the heart, lungs, liver, and kidneys were procured for transplantation. The liver was further split and transplanted into 2 recipients ( Figure 1A ). On posttransplant follow-up, the kidney of 1 recipient had to be explanted within the first week testing should be performed in transplant recipients and to better understand the impact of immunosuppressive therapy on IgE sensitization, we prospectively studied 5 atopic living-donor kidney recipients. All pollen-specific IgE and >90% of skin prick tests remained positive 7 days and 3 months after transplantation, indicating that early diagnosis of donor-derived IgE sensitization is possible. Importantly, we propose recommendations with respect to safety for recipients undergoing solid-organ transplantation from donors with a history of fatal anaphylaxis. Figure 1D ). These data indicated that de novo occurrence of specific IgE to recombinant peanut allergen IgE (Ara h1, 2, 3, and 6) may predict allergy transfer in SOT.
| Donor cases 2
The second donor had a history of wasp allergy and developed cardiac arrest after a wasp sting despite the self-application of epi- 
| Donor cases 3
The third donor had an anaphylactic reaction with cardiac ar- found, a serological marker that can be associated with severe allergic reactions to kiwi. 16 However, the serological analysis of the 3 recipients of this donor (ie, pancreas-kidney, heart-kidney, and liver) showed no peanut and kiwi IgE at 6 months' posttransplantation. Interestingly, the donor was also highly sensitized to animals (rCanf1:87 ISU-E, rCanf5 46 ISU-E, rEqu c1: 19 ISU-E), 
| Diagnosis of IgE sensitization early after transplantation
So far, it remains unclear whether IgE and allergy transfer are affected by the immunosuppressive therapy. Also, the important question about whether detection of IgE sensitization is possible early after transplantation is unanswered. 17 The overall number of IgE sensitizations of all 5 atopic recipients remained unchanged within the first 6 months after transplantation ( Figure 1E ). We therefore decided to study the impact of immunosuppressive therapy on IgE and allergy maintenance. To this purpose, we performed a prospective follow-up analysis on 5 symptomatic patients with pre-existing allergic rhinoconjunctivitis undergoing living donor kidney transplantation. None of the patients had been treated with antihistamines at the time of transplantation. All 5 patients received a standard induction and maintenance immunosuppressive therapy with basiliximab and methylprednisolone followed by oral tacrolimus, prednisone, and mycophenolate mofetil (Figure 2A ).
SPT and serological analysis were performed before, 7 days, and 
| D ISCUSS I ON
| Mechanisms of allergy transfer after SOT
As reviewed in the literature (Table 1) , allergy transfer was demonstrated after liver, lung, and pancreas transplantation, but so far not in heart and kidney recipients alone. One could therefore speculate that allergy transfer is a donor organ-specific phenomenon. Interestingly, in the case series reported by Berry et al, allergy transfer occurred in the pancreas-kidney recipient but not in the recipient of an isolated kidney, possibly because of the cotransplantation of a small bowel portion together with the pancreas. 6 These data suggest that kidney and heart tissues are less likely to contain sufficient IgG1-memory B cells (IgG1-MBcs) and/or IgE-producing B cells (IgE-Bcs) (Figure 3) . Thus, the majority of allergen-specific IgE in the blood does not originate from blood-derived B/plasma cells, suggesting that local IgE production in tissues is indeed the major source of allergen-specific IgE. 18 Furthermore, it is known that persistence of some tissueresident T cell clones can be organ-specific (ie, influenza-specific CD8+ T cells are predominantly found in the lungs whereas hepatitis-specific CD8 are predominantly found in the liver). 19 The fact that plasmatic IgE can be detected as early as 24 hours after transplantation and that it persists up to several months/ years suggests that the primary mechanism lies in the transfer of IgE-producing cells rather than in passive transfer of IgE only, because the half-life of free circulating IgE is known to be only 2 to 4 days. 20 Interestingly, several groups reported positive SPT without elevation of blood IgE, suggesting that IgE alone can be also passively transferred and secondarily binds to mastocytes, which increases IgE half-life (Table 1 and Figure 3 ). 21 Thus, SPT
and IgE serological analysis can be complementary in the diagnosis of allergy transfer. 
| Persistence of sensitization and allergy
The persistence of sensitization after allergy transfer in SOT recipients over time is poorly understood. In our series, LiverR1 had detectable IgE for >393 days ( Figure 1C ), which turned negative 2 years after transplantation, whereas in LiverSplitR2 peanut-specific IgE were positive for <53 days. LiverR1 received an extended liver graft and eventually increased number of passenger leukocytes, but on the other hand LiverSplitR2 has never been exposed to peanut before peanut-specific IgE levels turned negative. Thus, early exposure to allergen after SOT may lead to expansion of IgE-Bcs, or alternatively switch from IgG1-MBcs into IgE-producing cells 22 (Figure 3 ).
Interestingly, in lung transplant recipients, allergy transfer seems to persist longer than in liver recipients (Table 1) , probably due to the high amount of immune cells in human lung tissue including 100 000 mast cells per gram of tissue. 21 showing that previously nonasthmatic recipients can become asthmatic after lung transplantation from mildly asthmatic donors. 23 Finally, results from hematopoietic stem cell transplantation suggest that matured Th2-like cells or hematopoietic progenitor stem cells are also sufficient to induce and maintain long-term allergy transfer for (more) than 16 years. 24 Thus, duration and persistence of the transferred allergy status over time may depend on the organ transplanted and mechanisms of allergy transfer.
| Immunosuppression and allergy
Importantly, our data and that of others ( This finding is not surprising since donor-specific IgG-producing B cells can mediate acute and/or chronic allograft rejection, which are 2 conditions that are associated with limited response to therapy despite several lines of treatments. 25, 26 Interestingly, it is also known that IgG-producing "passenger lymphocytes" can mediate acute hemolysis or idiopathic thrombocytopenic purpura within the first 2 weeks after liver transplantation. [27] [28] [29] It has been previously shown that sensitization and allergy symptoms in children after SOT might not be controlled by immu- 
| Management and patient care
In summary, increased attention has to be given to the risk of allergy In conclusion, we demonstrate that SPT and IgE analysis can be performed as early as 7 days after transplantation. Therefore, postponing the allergological investigation is unnecessary. Prescription of antihistamines should be omitted in any case 7 days prior to SPT as per standard recommendation. 17 Finally, good medical practice would include a food challenge to prove tolerance (Figure 4 ).
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